The candidate “solution” to that problem is to remove any representation requirements in medical trials, so adverse effects that manifest just in specific subgr

The candidate “solution” to that problem is to remove any representation requirements in medical trials, so adverse effects that manifest just in specific subgroups aren’t found. I wish I were joking.